Nanotech Capital Raises in the U.S. – March 1st-15th, 2025
Several interesting transactions closed in the Nanotech sector over the past two weeks. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PIPE
-
- Aadi Bioscience, a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers, received approximately $100 million of development capital from OrbiMed, The Invus Group, Kalehua Capital Management, Ally Bridge Group, Avoro Capital, Acuta Capital Partners, KVP Capital and other investors.
- FendX Technologies Inc, a technology company focused on developing surface protection products that protect surfaces from pathogen contamination, received CAD 710,005 of development capital.
Later Stage VC
-
- En Solución, developer of agricultural technology designed for the farming industry, raised $8.73 million of venture funding from investors.
- Chimeron Bio, developer of self-amplifying therapeutics and vaccines intended to offer gene therapies and personalized medicines to patients, raised $13.74 million of venture funding.
#castleplacement #capitalraising #privateequity #venturecapital #investment #nanotech
Jesus Tueme
Managing Director
Finance and banking executive with a global perspective, broad professional practice and extensive network in Latin America. 22 years at BBVA, BNPP and Credit Agricole. Successful deal-making track record with multinationals, major Latin American issuers and government agencies. Extensive experience in restructuring/special situations, initial public offerings, corporate strategy, evaluating alliances, mergers and acquisitions, corporate governance, risk management, customer centric and digital strategies, and financial analytics. BS in Economics from Mexico Monterrey Institute of Technology. MBA from the University of California Los Angeles in 1987. Graduated from Harvard Business School General Management Program. Further academic work on Risk Management at Stanford University and as a research and finance scholar at the Monterrey Institute of Technology.
- Email: jtueme@castleplacement.com
- (C) (646) 479-7616
 Jesus TuemeManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: jtueme@castleplacement.com
(C) (646) 479-7616
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement™ does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
